IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jul 10, 2006
Insider Transaction Report
Form 4
WYNGAARDEN JAMES B
Director
Transactions
- Purchase
Common stock
2006-07-07$3.36/sh+968$3,250→ 33,149 total
Footnotes (1)
- [F1]The number of shares beneficially owned has been reduced in connection with the one-for-eight reverse split of the Company's common stock effective on June 29, 2006.